Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
36,378.800000 Euro
Request Reference:
A1/3120/2020 - Medicamento Bevacizumab
Request Name:
A1/3120/2020 - Medicamento Bevacizumab
Phase:
Tendering Phase
State:
Awarded
Description:
A1/3120/2020 - Medicamento Bevacizumab
Procedure Type:
VortalGOV - Urgent Open Tender
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua das Olhalvas - Pousos 2410-197 Leiria Leiria PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
10/22/2020 4:10 PM
(UTC +1 hour)
National official publishing date and time (DR):
10/22/2020 3:15 PM
(UTC +1 hour)
Due datetime for receiving replies:
10/27/2020 6:00 PM
(UTC 0 hours)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
A1 3120 Caderno de Encargos.pdf
A1 3120 Caderno de Encargos.pdf
Download
A1 3120 Programa procedimento.pdf
A1 3120 Programa procedimento.pdf
Download
Award and Contract Information
Award and Contract Information
Award
Award Date
Award Value
Award State
PT1.AWD.1151278
11/3/2020
30,579.20 Euro
Active
Awarded Company
Contract Value
Document(s)
Laboratórios PFizer, Lda.
30,579.20 Euro
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
Secção
1.1.1
Articulado da Consulta
*
(Os valores indicados não incluem o IVA)
Preço Total
Total without VAT
0.000000
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
118404350
Internal Reference
Description
Bevacizumab 100mg/4 ml sol inj IV
Qty
40.000000
Unit
FR/A
Price per Unit
Total
Comentários do Comprador:
artigo SPMS - B325
Reference
118404355
Internal Reference
Description
Bevacizumab 400mg/16 ml sol inj IV
Qty
40.000000
Unit
FR/A
Price per Unit
Total
Comentários do Comprador:
artigo SPMS - B326
Evaluation
Evaluation
Evaluation General Settings
Evaluation General Settings
Evaluation guideline
LowestPrice
Evaluation Method
Manual
Evaluation Items
Evaluation Items
Name
Lot
Critérios da Avaliação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...